Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 56
Filter
1.
Int J Immunopathol Pharmacol ; 19(1): 97-104, 2006.
Article in English | MEDLINE | ID: mdl-16569347

ABSTRACT

T cell responses are involved in vaccine-induced immunity to pertussis but no easy-to-monitor, serological markers are available to assess these responses. The lymphocyte activation gene-3 (CD223) molecule is present on, and released by, activated T helper (Th) 1 cells, whereas CD30 molecules have been associated with Th2 immune responses. Starting from the recent knowledge of the cytokine profile induced by pertussis vaccination, we examined the levels of soluble (s)CD223 and sCD30 proteins in child recipients of acellular pertussis (aP) and diphtheria-tetanus (DT) vaccines and in children receiving DT vaccine only, as control. The correlation of the two proteins with specific antibody and T cell responses was assessed. The main findings are: i) sCD223 and sCD30 levels are inversely related, suggesting that the two markers are the expression of different and counter-regulated T-cell responses; ii) sCD30 level correlated with induction of T cell proliferation to pertussis vaccine antigens and antibody response to pertussis toxin. Overall, sCD30 and sCD223 levels seem to be promising candidate markers to assess the induction of Th-type responses in vaccine recipients.


Subject(s)
Antigens, CD/metabolism , Cytokines/biosynthesis , Ki-1 Antigen/metabolism , Pertussis Vaccine/pharmacology , Th1 Cells/immunology , Th2 Cells/immunology , Antibodies, Bacterial/analysis , Antibodies, Bacterial/biosynthesis , Antigens, CD/analysis , Biomarkers , Child , Double-Blind Method , Humans , Immunity, Cellular/drug effects , Ki-1 Antigen/analysis , Th1 Cells/metabolism , Vaccines, Acellular/pharmacology , Lymphocyte Activation Gene 3 Protein
2.
J Biol Regul Homeost Agents ; 19(3-4): 136-40, 2005.
Article in English | MEDLINE | ID: mdl-16602628

ABSTRACT

Inflammatory processes contribute to the pathogenesis and complications of atherosclerosis and coronary heart disease (CHD). Several findings indicate that chlamydial heat shock proteins (HSP) may represent a particularly strong antigenic stimulus, able to induce specific humoral (Ab) and T-cell-mediated immune responses (CMI) linking infection by Chlamydia pneumoniae (CP) to immuno-pathological sequelae such as atherosclerosis and CHD. We have here evaluated the ability of chlamydial recombinant (r) HSP60 and rHSP10 to induce specific immune responses in human peripheral blood lymphocytes and in murine models. rHSP60, but not rHSP10, was shown to induce proliferation and Interferon-gamma secretion in lymphocytes of randomly selected blood donors, as well as to generate and detect delayed-type hypersensitivity response in HSP60-vaccinated mice. Overall, the present study provides new hints to evaluate a previous exposition to CP using rHSP60 in humans. Thus the evaluation of specific HSP60 CMI response in healthy subject could be useful to monitor the reactivity to Chlamydia pneumoniae possibly providing a link to CHD pathologies.


Subject(s)
Bacterial Proteins/immunology , Chaperonin 60/immunology , Chlamydophila pneumoniae/immunology , T-Lymphocytes/immunology , Animals , Antigens, Bacterial/genetics , Atherosclerosis/etiology , B-Lymphocytes/immunology , Bacterial Proteins/genetics , Chaperonin 60/genetics , Chlamydophila pneumoniae/genetics , Chlamydophila pneumoniae/pathogenicity , Coronary Disease/etiology , Humans , Immunization , In Vitro Techniques , Inflammation/etiology , Mice , Recombinant Proteins/genetics , Recombinant Proteins/immunology
3.
Clin Diagn Lab Immunol ; 10(4): 637-42, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12853397

ABSTRACT

The relative value of antibodies and/or T-cell immune responses to Bordetella pertussis antigens in the immunity induced by acellular pertussis (aP) vaccines is still an open issue, probably due to the incomplete knowledge on the mechanisms of protective immunity to pertussis. The relevance of T-cell immune responses in protection from pertussis has been demonstrated in murine and human models of infection; thus, in this study, the ability of different vaccine preparations of three component (pertussis toxin, filamentous hemagglutinin, and pertactin) aP vaccines to induce T-cell responses was investigated in mice. All vaccine preparations examined passed the immunogenicity control test, based on antibody titer assessment, according to European Pharmacopoeia standards, and protected mice from B. pertussis intranasal challenge, but not all preparations were able to prime T cells to pertussis toxin, the specific B. pertussis antigen. In particular, one vaccine preparation was unable to induce proliferation and gamma interferon (IFN-gamma) production while the other two gave borderline results. The evaluation of T-cell responses to pertussis toxin antigen may provide information on the protective immunity induced by aP vaccines in animal models. Considering the critical role of the axis interleukin-12-IFN-gamma for protection from pertussis, our results suggest that testing the induction of a key protective cytokine such as IFN-gamma could be an additional tool for the evaluation of the immune response induced by aP vaccines.


Subject(s)
Antibodies, Bacterial/blood , Bordetella pertussis/immunology , Interferon-gamma/biosynthesis , Pertussis Vaccine/immunology , T-Lymphocytes/immunology , Administration, Intranasal , Animals , Antigens, Bacterial/immunology , Female , Lung/microbiology , Lymphocyte Activation , Mice , Mice, Inbred BALB C , Mice, Inbred Strains , Specific Pathogen-Free Organisms , Vaccination , Vaccines, Acellular/immunology
4.
Int Immunol ; 13(4): 397-409, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11282979

ABSTRACT

Human CD38 is a signal transduction molecule, and, concurrently, an ectoenzyme catalyzing the synthesis and degradation of cyclic ADP-ribose (cADPR), a potent Ca2+ mobilizer. One facet of CD38 that has not yet been addressed is its role in NK cells. To this end, the events triggered by CD38 ligation with agonistic mAb were analyzed on freshly purified human NK cells. Ligation was followed by (i) a significant rise in the intracellular level of Ca2+, (ii) increased expression of HLA class II and CD25, and (iii) tyrosine phosphorylation of discrete cytoplasmic substrates. The phosphorylation cascade involved CD3-zeta and FcepsilonRIgamma chains, zeta-associated protein (ZAP)-70 and the proto-oncogene product c-Cbl. NK effector functions were then analyzed: CD38 signaling was able (iv) to induce release of IFN-gamma and, more prominently, of granulocyte macrophage colony stimulating factor, as assessed by measuring both mRNA and protein products; and, lastly, (v) to induce cytolytic effector functions on target cells after IL-2 activation, as shown both by cytotoxicity assays and ultrastructural changes. The tyrosine-phosphorylated substrates and all the effects mediated by CD38 were similar to those observed following triggering via CD16 (FcgammaRIIIA); moreover, Ca2+ mobilization via CD38 no longer operated in NK-derived cell lines lacking CD16. These results suggest that the activation signals transduced by CD38 in NK cells elicit relevant cellular events. The effects are similar to those elicited via CD16 and possibly rely on common signaling pathways.


Subject(s)
Antigens, CD , Antigens, Differentiation/immunology , Killer Cells, Natural/immunology , Lymphocyte Activation , ADP-ribosyl Cyclase , ADP-ribosyl Cyclase 1 , CD3 Complex/analysis , Calcium/metabolism , Cytotoxicity, Immunologic , Granulocyte-Macrophage Colony-Stimulating Factor/analysis , Histocompatibility Antigens Class II/analysis , Humans , Interferon-gamma/analysis , Interleukin-2/pharmacology , Killer Cells, Natural/drug effects , Membrane Glycoproteins , NAD+ Nucleosidase/immunology , Phosphorylation , Protein-Tyrosine Kinases/analysis , Protein-Tyrosine Kinases/metabolism , Proto-Oncogene Mas , Proto-Oncogene Proteins/analysis , RNA, Messenger/analysis , Receptors, IgE/analysis , Receptors, IgG/immunology , Receptors, Interleukin-2/analysis , Signal Transduction , Tyrosine/metabolism , ZAP-70 Protein-Tyrosine Kinase
6.
J Infect Dis ; 181(6): 1989-95, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10837180

ABSTRACT

Cell-mediated immunity (CMI) and antibody responses to Bordetella pertussis antigens were assessed 4-6 years after primary infant immunization with diphtheria-tetanus tricomponent acellular pertussis (DTaP) or diphtheria-tetanus (DT) vaccine in a country with high endemicity of B. pertussis infection. CMI to the B. pertussis antigens (especially to the pertussis toxin [PT]) was more frequent and/or intense in DTaP than in DT recipients. No lymphoproliferation differences were found between those with and without a history of pertussis although the DT recipients produced very little interferon-gamma after antigen (particularly PT and filamentous hemagglutinin [FHA]) stimulation. In contrast, seropositivity to PT, but not to pertactin or FHA, was more frequent in DT recipients with history of pertussis than in all other subjects. Thus, years after disease or vaccination, CMI response to PT or circulating PT antibodies appears to be the main distinctive feature of pertussis-protected DTaP recipients or pertussis-affected DT recipients.


Subject(s)
Antibodies, Bacterial/blood , Antigens, Bacterial/immunology , Bordetella pertussis/immunology , Diphtheria-Tetanus-Pertussis Vaccine/immunology , Whooping Cough/immunology , Child , Child, Preschool , Diphtheria Toxoid/immunology , Diphtheria-Tetanus Vaccine , Humans , Immunity, Cellular , Interferon-gamma/biosynthesis , Interleukin-5/biosynthesis , Tetanus Toxoid/immunology , Vaccines, Combined/immunology
7.
Tissue Antigens ; 56(6): 539-47, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11169244

ABSTRACT

In addition to its catalytic activities as ecto-NAD+ glycohydrolase (NADase), CD38 displays the ability to transduce signals of biological relevance. Indeed, ligation of CD38 on peripheral blood mononuclear cells (PBMC) by agonistic monoclonal antibodies (mAbs) is followed by the transcription and secretion of a vast array of regulatory cytokines. The present work addresses the issue of whether the signals leading to calcium (Ca2+) mobilization, lymphocyte proliferation and release of cytokines is dependent on the epitopes recognized by the individual mAbs. Competition binding analysis identifies two families of mAbs, namely IB4, IB6 and AT2 on one side and OKT10, SUN-4B7 and AT1 on the other. Each mAb family binds epitopes that are completely or partially common. However, the functional activities of the CD38 molecule can not be simply attributed to the epitopes engaged: for instance, IB4 and OKT10 mAbs, which bind different epitopes, perform as agonistic mAbs in inducing PBMC proliferation and interferon (IFN)-gamma secretion. SUN-4B7 yields intermediate effects, whereas IB6, AT1 and AT2 mAbs are totally ineffective. The effects mediated by IB4 and OKT10 mAbs are apparent in 80% of the healthy individuals studied, whereas the effects of SUN-4B7 mAb operate only in 25% of the donors. Interleukin (IL)-6 secretion was observed in all individuals analyzed, irrespective of the epitopes triggered and of mAbs used to ligate the CD38 molecule. In addition, IB4 is the only mAb able to induce significant intracellular Ca2+ fluxes.


Subject(s)
Antigens, CD , Antigens, Differentiation/chemistry , Antigens, Differentiation/immunology , Leukocytes, Mononuclear/immunology , NAD+ Nucleosidase/chemistry , NAD+ Nucleosidase/immunology , ADP-ribosyl Cyclase , ADP-ribosyl Cyclase 1 , Anti-Bacterial Agents/pharmacology , Antibodies, Monoclonal , Antigens, Differentiation/metabolism , Binding, Competitive/immunology , Calcium/metabolism , Cell Division/drug effects , Cell Division/immunology , Epitope Mapping , Humans , Interferon-gamma/immunology , Interferon-gamma/metabolism , Interleukin-6/immunology , Interleukin-6/metabolism , Leukocytes, Mononuclear/cytology , Leukocytes, Mononuclear/metabolism , Ligands , Lipopolysaccharides/antagonists & inhibitors , Membrane Glycoproteins , NAD+ Nucleosidase/metabolism , Polymyxin B/pharmacology , Protein Structure, Tertiary , Signal Transduction/immunology
8.
J Med Microbiol ; 48(12): 1081-1086, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10591161

ABSTRACT

The role of specific antibodies in protective immunity to Bordetella pertussis has not yet been clearly defined. In the present work, the induction of a specific antibody response to B. pertussis in cultures of human peripheral blood mononuclear cells (PBMC) was investigated, on the assumption that the capacity of circulating lymphocytes to mount a specific response in vitro may provide a useful parameter for the evaluation of protective immunity. When PBMC from normal adult donors were cultured with a heat-inactivated B. pertussis whole-cell suspension, cells secreting antibodies to pertussis toxin, pertactin and filamentous haemagglutinin were generated consistently. The antibody response peaked between days 7 and 11 of culture and the antibodies produced were exclusively of the IgM class.


Subject(s)
Antibodies, Bacterial/biosynthesis , Antigens, Bacterial/immunology , Bordetella pertussis/immunology , Leukocytes, Mononuclear/immunology , Adult , Blood Donors , Cells, Cultured , Humans , Immunoglobulin M/biosynthesis , Interleukin-2/immunology , Leukocytes, Mononuclear/microbiology , Middle Aged , Time Factors
9.
Biologicals ; 27(2): 119-21, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10600199

ABSTRACT

Over the last few years our laboratory has been assessing the consistency of production of different batches of acellular pertussis vaccines to be marketed in Italy. Central to this is immunogenicity assay of the lots under control compared with those of a reference vaccine with documented clinical efficacy.However, the current assays based on the assessment of antibody (Ab) response in the mouse are unrelated to mechanisms of protection in children. The absence of a clear correlation between Ab responses and protection has also been documented in recent clinical trials. On this basis, we are currently considering the possibility of adding to the established criteria of immunogenicity in mice based on Ab responses, information from studies on cell-mediated immune responses to the vaccine constituents.


Subject(s)
Diphtheria-Tetanus-Pertussis Vaccine/immunology , Diphtheria-Tetanus-Pertussis Vaccine/standards , Animals , Antibodies, Bacterial/biosynthesis , Diphtheria-Tetanus-acellular Pertussis Vaccines , Immunity, Cellular , Mice , Quality Control
10.
Infect Immun ; 67(8): 4064-71, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10417175

ABSTRACT

Cell-mediated immune (CMI) responses to Bordetella pertussis antigens (pertussis toxin [PT], pertactin [PRN], and filamentous hemagglutinin [FHA]) were assessed in 48-month-old recipients of acellular pertussis [aP] vaccines (either from Chiron-Biocine [aP-CB] or from SmithKline Beecham [aP-SB]) and compared to CMI responses to the same antigens at 7 months of age, i.e., 1 month after completion of the primary immunization cycle. None of the children enrolled in this study received any booster of pertussis vaccines or was affected by pertussis during the whole follow-up period. Overall, around 75% of 4-year-old children showed a CMI-positive response to at least one B. pertussis antigen, independently of the type of aP vaccine received, and the proportion of CMI responders were at least equal at 48 and 7 months of age. However, longitudinal examination of individual responses showed that from 20 (against PT) to 37% (against FHA) of CMI responders after primary immunization became negative at 48 months of age. This loss was more than compensated for by conversion to positive CMI responses, ranging from 36% against FHA to 69% against PRN, in other children who were CMI negative at 7 months of age. In 60 to 80% of these CMI converters, a lack of decline or even marked elevation of antibody (Ab) titers against B. pertussis antigens also occurred between 20 and 48 months of age. In particular, the frequency of seropositivity to PRN and FHA (but not to PT) was roughly three times higher in CMI converters than in nonconverters. The acquisition of CMI response to B. pertussis antigens in 48-month-old children was not associated with a greater frequency of coughing episodes lasting >/=7 days and was characterized by a prevalent type 1 cytokine profile, with high gamma interferon and low or no production of interleukin-5, reminiscent of cytokine patterns following immunization with whole-cell pertussis vaccine or natural infection. Our data imply that vaccination-induced systemic CMI may wane by 4 years of age but may be acquired or naturally boosted by symptomless or minor clinical infection by B. pertussis. This might explain, at least in part, the persistence of protection against typical pertussis in aP vaccine recipients despite a substantial waning of both Ab and CMI responses induced by the primary immunization.


Subject(s)
Lymphocyte Activation , Pertussis Vaccine/immunology , Antibodies, Bacterial/blood , Antigens, Bacterial/immunology , Bordetella pertussis/immunology , Child, Preschool , Cytokines/biosynthesis , Humans , Immunization , Infant
11.
J Infect Dis ; 178(2): 466-70, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9697728

ABSTRACT

Cell-mediated immunity (CMI) to Bordetella pertussis and acellular pertussis vaccine constituents (pertussis toxin, pertactin, and filamentous hemagglutinin) were studied in peripheral blood mononuclear cells (PBMC) and T cell cultures from healthy adults with no record of vaccination against, or history of, pertussis. Similarly to stimulation with common recall antigens, PBMC proliferation was induced in 80%-100% of the cultures, depending on the specific B. pertussis stimulant. Proliferation did not occur when antigen-presenting cells were ablated by chemical or physical methods or with naive cord blood lymphocytes. B. pertussis antigen stimulation resulted in a preferential induction of type 1 cytokine profile, as shown by interferon-gamma and interleukin-2 (but no interleukin-4 or interleukin-5) gene transcripts and actual cytokine production by T cells. The data suggest that most healthy adults are repeatedly exposed to B. pertussis, with natural acquisition of antigen-specific CMI and a putatively protective type 1 cytokine pattern.


Subject(s)
Antigens, Bacterial/immunology , Bordetella pertussis/immunology , Immunity, Cellular , Pertussis Vaccine/immunology , Adhesins, Bacterial/immunology , Adult , Bacterial Outer Membrane Proteins/immunology , Cell Division , Cells, Cultured , Cytokines/biosynthesis , Cytokines/genetics , Hemagglutinins/immunology , Humans , Leukocytes, Mononuclear/immunology , Lymphocyte Activation/immunology , Middle Aged , Pertussis Toxin , T-Lymphocytes/immunology , Virulence Factors, Bordetella/immunology
13.
J Biol Regul Homeost Agents ; 12(1-2): 33-7, 1998.
Article in English | MEDLINE | ID: mdl-9677533

ABSTRACT

In previous studies, we have reported that the intraperitoneal (i.p.) injection of HIV-1 infected human U937 cells into normal mice resulted in long-term persistence of anti-HIV antibodies and in a small percentage (10-20%) of HIV-1 infected animals at 6-12 months after the injection. The study reported here was undertaken to detect T immune defects in U937-HIV-1-injected mice. Eight months after the initial injection, a marked decrease in DTH response against U937 cells was detected in HIV injected animals. In addition, a consistent decrease in DTH response against a soluble mannoprotein antigen of Candida albicans cell wall (MP-F2) was also observed in U937-HIV-1-injected mice, chronically infected with low-virulent strain of the fungus. No decreases in DTH response was observed in control-injected animals. These data indicate that U937-HIV-1-injected mice become unable to mount a normal antigen-specific immune response. Although the mechanisms involved in the generation of these T cell defects remain unclear, these events appear to be somehow related to the HIV-1 infection and should be considered in the current studies of HIV-1 infection with transgenic mice.


Subject(s)
Candida albicans/pathogenicity , Candidiasis/immunology , HIV Infections/immunology , HIV-1 , Hypersensitivity, Delayed/immunology , Animals , Clonal Anergy , Disease Models, Animal , Fungal Proteins/pharmacology , Humans , Hypersensitivity, Delayed/virology , Lymphoma/virology , Male , Membrane Glycoproteins/pharmacology , Mice , Mice, Inbred Strains , Neoplasm Transplantation
14.
Cell Immunol ; 186(1): 28-38, 1998 May 25.
Article in English | MEDLINE | ID: mdl-9637762

ABSTRACT

Human interleukin-2-activated natural killer (LAK) cells are able to recognize and to bind to both live and heat-killed germ tube forms of Candida albicans, establishing a wide and intimate contact as revealed by electron microscopic observations. Following the interaction, LAK cells are activated: an increased expression of some cytokine mRNA (in particular, TNF-alpha, GM-CSF, and IFN-gamma) has been revealed by RT-PCR and perforin secretion has been suggested by immunofluorescence microscopy. Nonetheless, neither morphological damage or growth inhibition of fungal target cells have been detected. Instead, evident signs of cell damage could be noticed in interacting LAK cells. Moreover, the observation by transmission electron microscopy of LAK cell-germ tube conjugates revealed the presence of apoptotic cells. The analysis of LAK cell cytotoxic activity against DAUDI cells showed that the lymphocytic effector underwent a significant reduction in its lytic capability after the interaction with C. albicans. The results obtained in this in vitro study seem to indicate that in such an interaction LAK cells cannot directly inhibit or kill the fungal pathogen by using their lytic machinery but they secrete those cytokines which have stimulatory effects on phagocytic cells. The ultimate results are the programmed death of LAK cells and the enhancement of the fungicidal activity exerted by competent cells.


Subject(s)
Candida albicans/immunology , Interleukin-2/pharmacology , Killer Cells, Natural/immunology , Cytokines/genetics , Cytotoxicity Tests, Immunologic , Hot Temperature , Humans , Killer Cells, Natural/drug effects , Killer Cells, Natural/ultrastructure , Membrane Glycoproteins/genetics , Microscopy, Electron , Perforin , Pore Forming Cytotoxic Proteins , RNA, Messenger , Recombinant Proteins/pharmacology
15.
Infect Immun ; 66(5): 2154-62, 1998 May.
Article in English | MEDLINE | ID: mdl-9573102

ABSTRACT

The 70-kDa recombinant Candida albicans heat shock protein (CaHsp70) and its 21-kDa C-terminal and 28-kDa N-terminal fragments (CaHsp70-Cter and CaHsp70-Nter, respectively) were studied for their immunogenicity, including proinflammatory cytokine induction in vitro and in vivo, and protection in a murine model of hematogenous candidiasis. The whole protein and its two fragments were strong inducers of both antibody (Ab; immunoglobulin G1 [IgG1] and IgG2b were the prevalent isotypes) and cell-mediated immunity (CMI) responses in mice. CaHsp70 preparations were also recognized as CMI targets by peripheral blood mononuclear cells of healthy human subjects. Inoculation of CaHsp70 preparations into immunized mice induced rapid production of interleukin-6 (IL-6) and tumor necrosis factor alpha, peaking at 2 to 5 h and declining within 24 h. CaHsp70 and CaHsp70-Cter also induced gamma interferon (IFN-gamma), IL-12, and IL-10 but not IL-4 production by CD4+ lymphocytes cocultured with splenic accessory cells from nonimmunized mice. In particular, the production of IFN-gamma was equal if not superior to that induced in the same cells by whole, heat-inactivated fungal cells or the mitogenic lectin concanavalin A. In immunized mice, however, IL-4 but not IL-12 was produced in addition to IFN-gamma upon in vitro stimulation of CD4+ cells with CaHsp70 and CaHsp70-Cter. These animals showed a decreased median survival time compared to nonimmunized mice, and their mortality was strictly associated with organ invasion by fungal hyphae. Their enhanced susceptibility was attributable to the immunization state, as it did not occur in congenitally athymic nude mice, which were unable to raise either Ab or CMI responses to CaHsp70 preparations. Together, our data demonstrate the elevated immunogenicity of CaHsp70, with which, however, no protection against but rather some enhancement of Candida infection seemed to occur in the mouse model used.


Subject(s)
Candida albicans/immunology , Candidiasis/etiology , Fungal Proteins/immunology , HSP70 Heat-Shock Proteins/immunology , Animals , Antibodies, Fungal/biosynthesis , CD4-Positive T-Lymphocytes/metabolism , Cytokines/blood , Humans , Immunity, Cellular , Mice , Mice, Inbred C3H , Recombinant Proteins/immunology
16.
J Immunol ; 160(1): 395-402, 1998 Jan 01.
Article in English | MEDLINE | ID: mdl-9551996

ABSTRACT

Human CD38 is a cell surface molecule involved in the regulation of lymphocyte adhesion to endothelial cells. This suggests that HUVEC bear a ligand(s) for CD38 on the cell surface. By means of the mAb Moon-1, which specifically inhibits CD38-mediated cell adhesion, we have identified a trans-membrane 130-kDa molecule acting as a ligand for CD38. Here, we report that the molecule recognized by the Moon-1 mAb is CD31, a member of the Ig superfamily. This conclusion is based on 1) cross-inhibition assays between Moon-1 and reference anti-CD31 mAbs; 2) sequential immunoprecipitation experiments using Moon-1 and known anti-CD31 mAbs, and 3) reactivity of the Moon-1 mAb with CD31 transfectants. Further, CD31 and CD38 cognate interactions were found to modulate heterotypic adhesion as well as to implement cytoplasmic calcium fluxes identical to those obtained by means of agonistic anti-CD38 mAbs. Other effects tested included the synthesis of messages for a panel of cytokines, markedly increased upon receptor-ligand interactions. These results suggest that the interplay between CD38 and its ligand CD31 is an important step in the regulation of cell life and of the migration of leukocytes (and CD38+ cancer cells) through the endothelial cell wall.


Subject(s)
Antigens, CD , Antigens, Differentiation/physiology , NAD+ Nucleosidase/physiology , Platelet Endothelial Cell Adhesion Molecule-1/physiology , Receptors, Immunologic , ADP-ribosyl Cyclase , ADP-ribosyl Cyclase 1 , Antibodies, Monoclonal , Calcium/physiology , Cell Adhesion Molecules/physiology , Cytokines/genetics , Down-Regulation , Endothelium, Vascular/immunology , Humans , Jurkat Cells , Membrane Glycoproteins , RNA, Messenger/genetics , Recombinant Proteins
17.
Clin Infect Dis ; 26(2): 297-302, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9502445

ABSTRACT

Titers of serum antibody and cell-mediated immunity (CMI) to Bordetella pertussis antigens were assessed in a cohort of Italian military school students for whom the coverage of pertussis vaccination was low. The overall prevalence of IgG antibody above the minimum level of detection (MLD) was 71.6% for pertussis toxin (PT), 81% for pertactin (PRN), and 99% for filamentous hemagglutinin (FHA). Levels of IgA antibody to PT above the MLD were detected in 15.9% of the study participants. CMI to FHA, PRN, and PT was positive in 97%, 100%, and 82% of tested individuals, respectively. Only 9.7% of the participants had neither antibody nor CMI specific to B. pertussis antigens. In the 5-month clinical, microbiological, and serological follow-up conducted during a high-risk period of pertussis, no cases of pertussis were detected. These data, in particular CMI, demonstrate that most Italian young adults are specifically primed against B. pertussis, which should be taken into consideration when future policy on pertussis vaccination is being made in Italy.


Subject(s)
Whooping Cough/epidemiology , Adolescent , Adult , Antibodies, Bacterial/blood , Biomarkers , Cross-Sectional Studies , Follow-Up Studies , Humans , Immunity, Cellular , Italy/epidemiology , Male , Prevalence , Whooping Cough/blood , Whooping Cough/immunology
18.
Infect Immun ; 65(6): 2168-74, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9169747

ABSTRACT

Cytokine profiles were examined 1 month after primary vaccination of infants with a whole-cell pertussis vaccine (wP) (Connaught) or either of two acellular pertussis vaccines, aP-Chiron Biocine (aP-CB) or aP-SmithKline Beecham (aP-SB), each combined with diphtheria-tetanus toxoids (DT), in Bordetella pertussis antigen-stimulated or unstimulated peripheral blood mononuclear cells (PBMC). Pertussis toxin (PT), filamentous hemagglutinin (FHA), and pertactin (PRN) were used as antigens, and the children were defined as responsive when their PBMC proliferated in response to these antigens. The controls were either children who received only DT or children who received pertussis vaccine but whose PBMC did not proliferate upon stimulation with B. pertussis antigens (unresponsive children). Antigen-stimulated PBMC of responsive wP recipients were characterized by an elevated production of T-helper-cell type 1 cytokines gamma interferon (IFN-gamma) and interleukin 2 (IL-2), low to minimal production of IL-5, and no production of IL-4. The PBMC of aP vaccine-responsive recipients showed, in addition to the elevated IFN-gamma production, a consistent, antigen-dependent production of type 2 cytokines (IL-4 and IL-5), with PRN being the most and PT being the least effective antigen. Type 2 cytokine induction was more pronounced in aP-SB than in aP-CB recipients, as shown by the presence of IL-4 mRNA transcripts and higher IL-5 production in the former (161.6 +/- 36 and 47.9 +/- 44 pg/ml [mean +/- standard error for five subjects each], respectively, after PRN stimulation). Appreciable, antigen-unstimulated (constitutive) IFN-gamma production was also detected in PBMC cultures of all vaccinees. However, this spontaneous IFN-gamma production was, in most vaccinees, significantly lower than the antigen-driven cytokine production. In contrast, no constitutive type 2 cytokine production was ever observed in any vaccine group. PBMC from the two control groups (either DT or pertussis vaccine recipients) did not show any type 2 cytokine production, while IFN-gamma production was comparable in both antigen-stimulated and unstimulated conditions. Absence of type 2 cytokines and low levels of constitutive IFN-gamma production were also seen in prevaccination children. Thus, pertussis vaccines induce in infants a basically type 1 cytokine profile, which is, however, accompanied by some production of type 2 cytokines. The latter are more expressed by aP-SB than by aP-CB recipients, and with PRN than with other antigens, and they are minimally expressed in wP recipients and with PT as antigen. Our data also highlight a constitutive IFN-gamma production in infancy, which might reflect natural immunization and/or the burden of concomitant vaccinations and which may have an impact on T-helper-cell cytokine pattern polarization consequent to pertussis vaccination.


Subject(s)
Antigens, Bacterial/immunology , Bordetella pertussis/immunology , Cytokines/biosynthesis , Pertussis Vaccine/immunology , Cytokines/genetics , Double-Blind Method , Humans , Immunity, Cellular , Infant , Interferon-gamma/biosynthesis , RNA, Messenger/analysis , Vaccination
19.
Arch Pediatr Adolesc Med ; 151(3): 283-9, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9080938

ABSTRACT

OBJECTIVE: To examine induction and persistence of cell-mediated immunity (CMI) and antibody responses to Bordetella pertussis antigens in infants receiving antipertussis vaccines. DESIGN AND SETTING: A randomized, blinded study of 142 children receiving acellular pertussis vaccines combined with diphtheria-tetanus toxoids (DTaP) (DTaP manufactured by SmithKline Beecham [DTaP-SB], Rixensart, Belgium, and DTaP manufactured by Chiron Biocin [DTaP-CB], Siena, Italy), or a whole-cell pertussis vaccine (DTwP) (Connaught Laboratories Inc, Swiftwater, Pa), or a diphtheria-tetanus (DT) (Chiron Biocine) only vaccine. Three doses of each vaccine were given at 2, 4, and 6 months of age, and CMI and antibody responses were evaluated before and at 1 and 14 months after vaccination. METHODS AND MAIN OUTCOME MEASURES: Cell-mediated immunity was assessed by proliferation of peripheral blood mononuclear cells stimulated in vitro by B pertussis antigens (pertussis toxin, filamentous hemagglutinin, and pertactin). Antibody titers against pertussis toxin, filamentous hemagglutinin, and pertactin were determined by a standardized enzyme-linked immunosorbent assay. RESULTS: A CMI-positive response to at least 1 B pertussis antigen at 1 or both postvaccination assays was detected in 46%, 55%, and 83% of DTwP, DTaP-SB, and DTaP-CB vaccine recipients, respectively. Frequency of CMI response to individual antigens ranged from less than 4.9% against pertussis toxin in DTwP recipients to 52% against pertactin in DTaP-CB recipients. The postvaccination responses measured at 14 months equalled, or had increased frequency or intensity, that of the 1-month postvaccination responses. Elevated antibody titers against the 3 antigens were present in all DTaP recipients 1 month after vaccination and were higher in CMI-positive children than in CMI-negative children. They fell, however, to low, if not negligible, levels 14 months after vaccination. CONCLUSIONS: Acellular pertussis vaccines were better inducers of CMI response than the whole-cell vaccine, particularly against pertussis toxin. Once acquired, CMI persisted, in contrast with the rapid antibody decline. Thus, CMI responses could be a useful adjunct to serology in the evaluation of pertussis vaccine immunogenicity and a better correlate of long-term immunity to B pertussis than antibody titers.


Subject(s)
Bordetella pertussis/immunology , Diphtheria-Tetanus-Pertussis Vaccine/therapeutic use , Immunity, Cellular , Whooping Cough/prevention & control , Double-Blind Method , Humans , Immunization Schedule , Infant , Placebos
20.
Clin Exp Immunol ; 107(3): 451-7, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9067516

ABSTRACT

IL-1beta, IL-6, IL-8 and TNF-alpha production by PMNL from 21 HIV-infected (HIV+), including 11 full-blown AIDS, and 20 HIV-uninfected (HIV-) subjects (matched for age and sex to HIV+ ones) was studied by reverse transcriptase-polymerase chain reaction (RT-PCR) and ELISA. PMNL from both categories of subjects were strongly stimulated in their actual cytokine production by a mannoprotein fraction (MP-F2) of Candida albicans, as well as by the bacterial lipopolysaccharide (LPS). These stimulatory effects were apparently due to increased cytokine gene expression and were substantially reversed by the physiological inhibitor IL-10. However, PMNL from HIV+ subjects showed increased IL-6 and TNF-alpha gene expression and produced more IL-6 and TNF-alpha than PMNL from HIV- controls, under similar stimulation conditions. This difference could not be attributed to a given stage of HIV infection, any associated medication, or to a generalized increase of gene expression, as quantitatively similar beta-actin and IL-1beta transcripts were detected. Moreover, no significant difference in IL-8 production by the PMNL from HIV+ and HIV- subjects was observed. Our studies suggest that PMNL from HIV+ subjects might add to other cellular sources of IL-6 and TNF-alpha (e.g. monocytes-macrophages) in contributing to the cytokine-dysregulated pattern typical of the HIV+ patient.


Subject(s)
Fungal Proteins/immunology , HIV Infections/immunology , Interleukin-6/biosynthesis , Membrane Glycoproteins/immunology , Neutrophil Activation/immunology , Neutrophils/microbiology , Peptide Fragments/immunology , Tumor Necrosis Factor-alpha/biosynthesis , Adult , Candida albicans/immunology , Cells, Cultured , Female , Fungal Proteins/pharmacology , HIV Infections/metabolism , Humans , Interleukin-1/biosynthesis , Interleukin-10/pharmacology , Interleukin-8/biosynthesis , Male , Membrane Glycoproteins/pharmacology , Middle Aged , Neutrophil Activation/drug effects , Neutrophils/drug effects , Neutrophils/metabolism , Peptide Fragments/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...